JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was THB 174.44 million compared to THB 107.74 million a year ago. Net income was THB 3.53 million compared to net loss of THB 4.71 million a year ago. Basic earnings per share from continuing operations was THB 0.01 compared to basic loss per share from continuing operations of THB 0.01 a year ago. Diluted earnings per share from continuing operations was THB 0.01 compared to diluted loss per share from continuing operations of THB 0.01 a year ago.
For the nine months, revenue was THB 425.41 million compared to THB 306.79 million a year ago. Net loss was THB 7.96 million compared to THB 28.14 million a year ago. Basic loss per share from continuing operations was THB 0.02 compared to THB 0.06 a year ago. Diluted loss per share from continuing operations was THB 0.02 compared to THB 0.06 a year ago.